Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IncobotulinumtoxinA for Rosacea of the Cheek
NCT01614743Phase 2Completed
- Sponsor
- DeNova Research
- Start
- Jun 2012
- Primary completion
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rosacea comparing IncobotulinumtoxinA with Placebo -> IncobotulinumtoxinA (2 arms). Primary endpoints: Percent Change From Baseline in the Rosacea Clinical Score Card at 20 weeks and Number of Participants Experiencing Adverse Events at 20 weeks. Started Jun 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT01614743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614743.